Business Description
Ferozsons Laboratories Ltd
ISIN : PK0005201014
Compare
Compare
Traded in other countries / regions
FEROZ.Pakistan IPO Date
1960-09-08Description
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.52 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 2.13 | |||||
| Interest Coverage | 2.2 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.26 | |||||
| Beneish M-Score | -2.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.3 | |||||
| 3-Year EBITDA Growth Rate | 5.2 | |||||
| 3-Year EPS without NRI Growth Rate | -19.6 | |||||
| 3-Year Book Growth Rate | 14.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.05 | |||||
| 9-Day RSI | 31.99 | |||||
| 14-Day RSI | 40.6 | |||||
| 6-1 Month Momentum % | 43.79 | |||||
| 12-1 Month Momentum % | 64.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 193.69 | |||||
| Days Sales Outstanding | 56.14 | |||||
| Days Payable | 104.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.88 | |||||
| Forward Dividend Yield % | 0.88 | |||||
| 5-Year Yield-on-Cost % | 0.87 | |||||
| Shareholder Yield % | -11.74 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.34 | |||||
| Operating Margin % | 9.96 | |||||
| Net Margin % | 4.01 | |||||
| FCF Margin % | -7.37 | |||||
| ROE % | 6.99 | |||||
| ROA % | 3.41 | |||||
| ROIC % | 7.68 | |||||
| ROC (Joel Greenblatt) % | 13.48 | |||||
| ROCE % | 14.29 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.74 | |||||
| PE Ratio without NRI | 22.74 | |||||
| Shiller PE Ratio | 16.68 | |||||
| PEG Ratio | 1.21 | |||||
| PS Ratio | 0.91 | |||||
| PB Ratio | 1.27 | |||||
| Price-to-Tangible-Book | 1.28 | |||||
| EV-to-EBIT | 9.88 | |||||
| EV-to-EBITDA | 7.31 | |||||
| EV-to-Revenue | 1.08 | |||||
| EV-to-Forward-Revenue | 0.5 | |||||
| EV-to-FCF | -14.64 | |||||
| Price-to-Median-PS-Value | 0.68 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.48 | |||||
| Price-to-Graham-Number | 1.14 | |||||
| Earnings Yield (Greenblatt) % | 10.12 | |||||
| FCF Yield % | -7.93 | |||||
| Forward Rate of Return (Yacktman) % | 8.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ferozsons Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₨) | 15,955.195 | ||
| EPS (TTM) (₨) | 14.73 | ||
| Beta | 0 | ||
| Volatility % | 37.06 | ||
| 14-Day RSI | 40.6 | ||
| 14-Day ATR (₨) | 18.219443 | ||
| 20-Day SMA (₨) | 356.848 | ||
| 12-1 Month Momentum % | 64.95 | ||
| 52-Week Range (₨) | 190 - 393 | ||
| Shares Outstanding (Mil) | 43.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ferozsons Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ferozsons Laboratories Ltd Stock Events
| Event | Date | Price(₨) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ferozsons Laboratories Ltd Frequently Asked Questions
What is Ferozsons Laboratories Ltd(KAR:FEROZ)'s stock price today?
The current price of KAR:FEROZ is ₨335.02. The 52 week high of KAR:FEROZ is ₨393.00 and 52 week low is ₨190.00.
When is next earnings date of Ferozsons Laboratories Ltd(KAR:FEROZ)?
The next earnings date of Ferozsons Laboratories Ltd(KAR:FEROZ) is .
Does Ferozsons Laboratories Ltd(KAR:FEROZ) pay dividends? If so, how much?
The Dividend Yield %  of Ferozsons Laboratories Ltd(KAR:FEROZ) is 0.88% (As of Today), Highest Dividend Payout Ratio of Ferozsons Laboratories Ltd(KAR:FEROZ) was 17.36. The lowest was 0.11. And the median was 0.51. The  Forward Dividend Yield % of Ferozsons Laboratories Ltd(KAR:FEROZ) is 0.88%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers